Urology
Multicomponent Intervention Aids Quality of Life With Overactive Bladder
Intervention included cognitive components and also improved frequency, urgency
Life Expectancy Increased From 2021 to Reach 77.5 Years in 2022
Second study shows age-adjusted rate of drug overdose deaths increased from 2002 to 2022, but did not change from 2021 to 2022
Survival Up With Enfortumab Vedotin + Pembrolizumab in Urothelial Cancer
Significantly longer progression-free and overall survival seen in patients with previously untreated locally advanced or metastatic urothelial carcinoma
Neoadjuvant Chemo Adds Significant Treatment Benefit in Penile Cancer
In a recent study, median overall survival with neoadjuvant chemotherapy, lymphadenectomy was 37.0 months
Obstructive Sleep Apnea Linked to Bladder Pain/Interstitial Cystitis
Women with OSA have higher median Interstitial Cystitis Symptom Index, Interstitial Cystitis Problem Index
Higher Use of Health Care Portal Seen During COVID-19 Pandemic
Lower portal activity linked to older age, female sex and for Hispanic/Latinx, non-Hispanic Black, and other race patients
Food Insecurity Correlated to Higher Risk for Overactive Bladder
Greater severity of food insecurity further heightens risk for overactive bladder
Observed Rates of Cancer Diagnoses Lower Than Expected in Pandemic
Rate of all-sites cancer incidence was 28.6 percent lower than expected during the height of the COVID-19 pandemic response
Increased Cancer Risk Seen in Families of Men With Subfertility
In a recent study, 13 clusters of familial multicancer patterns identified in families of azoospermic men
Disparities in Transgender Prostate Screening Uptake Driven by Clinicians
Clinician-led recommendations for and discussions of PSA screening explained differences between cisgender and transgender screening rates
